| Year |
Citation |
Score |
| 2023 |
Sarayani A, Brown JD, Hampp C, Donahoo WT, Winterstein AG. Adaptability of High Dimensional Propensity Score Procedure in the Transition from ICD-9 to ICD-10 in the US Healthcare System. Clinical Epidemiology. 15: 645-660. PMID 37274833 DOI: 10.2147/CLEP.S405165 |
0.376 |
|
| 2023 |
Sarayani A, Donahoo WT, Hampp C, Brown JD, Winterstein AG. Assessment of the Risk Evaluation and Mitigation Strategy (REMS) for Phentermine-Topiramate to Prevent Exposure During Pregnancy. Annals of Internal Medicine. PMID 36940443 DOI: 10.7326/M22-1743 |
0.443 |
|
| 2022 |
Sarayani A, Hampp C, Brown JD, Donahoo WT, Winterstein AG. Topiramate Utilization After Phentermine/Topiramate Approval for Obesity Management: Risk Minimization in the Era of Drug Repurposing. Drug Safety. PMID 36318419 DOI: 10.1007/s40264-022-01244-6 |
0.423 |
|
| 2021 |
Choi Y, Meissner HC, Hampp C, Park H, Winterstein AG. Utilization of chronic lung disease treatment before the respiratory syncytial virus season as palivizumab prophylaxis qualifier in the American Academy of Pediatrics Guidelines. European Journal of Pediatrics. PMID 34365543 DOI: 10.1007/s00431-021-04233-6 |
0.453 |
|
| 2020 |
Choi Y, Meissner HC, Hampp C, Park H, Brumback B, Winterstein AG. Calibration of Chronic Lung Disease Severity as a Risk Factor for Respiratory Syncytial Virus Hospitalization. Journal of the Pediatric Infectious Diseases Society. PMID 32978942 DOI: 10.1093/jpids/piaa107 |
0.477 |
|
| 2020 |
Zhu Y, Hampp C, Wang X, Albogami Y, Wei YJ, Brumback BA, Roussos-Ross D, Winterstein AG. Validation of algorithms to estimate gestational age at birth in the Medicaid Analytic eXtract-Quantifying the misclassification of maternal drug exposure during pregnancy. Pharmacoepidemiology and Drug Safety. PMID 32909348 DOI: 10.1002/Pds.5126 |
0.477 |
|
| 2019 |
Choi Y, Park H, Hampp C, Brumback B, Meissner HC, Li Y, Roussos-Ross D, Zhu Y, Henriksen C, Winterstein AG. Usability of encounter data for Medicaid comprehensive managed care vs traditional Medicaid fee-for-service claims among pregnant women. Pharmacoepidemiology and Drug Safety. PMID 31737976 DOI: 10.1002/Pds.4923 |
0.454 |
|
| 2019 |
Knox CA, Hampp C, Palmsten K, Zhu Y, Setoguchi S, Brumback B, Segal R, Winterstein AG. Validation of mother-infant linkage using Medicaid Case ID variable within the Medicaid Analytic eXtract (MAX) database. Pharmacoepidemiology and Drug Safety. PMID 31286606 DOI: 10.1002/Pds.4843 |
0.477 |
|
| 2017 |
McCarren M, Hampp C, Gerhard T, Mehta S. Recommendations on the use and nonuse of the p value in biomedical research. American Journal of Health-System Pharmacy : Ajhp : Official Journal of the American Society of Health-System Pharmacists. 74: 1262-1266. PMID 28790078 DOI: 10.2146/Ajhp160443 |
0.53 |
|
| 2016 |
Budnitz DS, Lovegrove MC, Sapiano MR, Mathew J, Kegler SR, Geller AI, Hampp C. Notes from the Field: Pediatric Emergency Department Visits for Buprenorphine/Naloxone Ingestion - United States, 2008-2015. Mmwr. Morbidity and Mortality Weekly Report. 65: 1148-1149. PMID 27764078 DOI: 10.15585/Mmwr.Mm6541A5 |
0.302 |
|
| 2015 |
Knox C, Hampp C, Willy M, Winterstein AG, Dal Pan G. Patient understanding of drug risks: an evaluation of medication guide assessments. Pharmacoepidemiology and Drug Safety. 24: 518-25. PMID 25808393 DOI: 10.1002/Pds.3762 |
0.493 |
|
| 2015 |
Knox C, Hampp C, Willy M, Winterstein AG, Pan GD. Patient understanding of drug risks: An evaluation of medication guide assessments Pharmacoepidemiology and Drug Safety. 24: 518-525. DOI: 10.1002/pds.3762 |
0.442 |
|
| 2014 |
Lovegrove MC, Mathew J, Hampp C, Governale L, Wysowski DK, Budnitz DS. Emergency hospitalizations for unsupervised prescription medication ingestions by young children. Pediatrics. 134: e1009-16. PMID 25225137 DOI: 10.1542/Peds.2014-0840 |
0.305 |
|
| 2013 |
Winterstein AG, Knox CA, Kubilis P, Hampp C. Appropriateness of age thresholds for respiratory syncytial virus immunoprophylaxis in moderate-preterm infants a cohort study Jama Pediatrics. 167: 1118-1124. PMID 24126903 DOI: 10.1001/Jamapediatrics.2013.2636 |
0.527 |
|
| 2013 |
Hampp C, Asal N, Lipowski E, Kauf T, Schneider E, Kubilis P, Winterstein A. Validity of laboratory-based surveillance for detection of respiratory syncytial virus seasons American Journal of Epidemiology. 177: 841-851. PMID 23479344 DOI: 10.1093/Aje/Kws304 |
0.552 |
|
| 2012 |
Hampp C, Kauf TL, Saidi AS, Winterstein AG. Methodological Concerns Regarding Cost-effectiveness Analysis of Palivizumab in Florida Medicaid-Reply. Archives of Pediatrics & Adolescent Medicine. 166: 968-70. PMID 23753905 DOI: 10.1001/Archpediatrics.2012.1594 |
0.469 |
|
| 2012 |
Eworuke E, Hampp C, Saidi A, Winterstein AG. An algorithm to identify preterm infants in administrative claims data Pharmacoepidemiology and Drug Safety. 21: 640-650. PMID 22504840 DOI: 10.1002/Pds.3264 |
0.506 |
|
| 2012 |
Winterstein AG, Hampp C, Saidi A. Effectiveness of palivizumab prophylaxis in infants and children in Florida Pharmacoepidemiology and Drug Safety. 21: 53-60. PMID 21919115 DOI: 10.1002/Pds.2246 |
0.532 |
|
| 2012 |
Hampp C, Kauf TL, Saidi AS, Winterstein AG. In reply Archives of Pediatrics and Adolescent Medicine. 166: 969-970. DOI: 10.1001/archpediatrics.2012.1594 |
0.338 |
|
| 2011 |
Hampp C, Kauf TL, Saidi AS, Winterstein AG. Cost-effectiveness of respiratory syncytial virus prophylaxis in various indications Archives of Pediatrics and Adolescent Medicine. 165: 498-505. PMID 21300647 DOI: 10.1001/Archpediatrics.2010.298 |
0.55 |
|
| 2010 |
Hampp C, Kauf TL, Winterstein AG. Small budget impact is a result of flawed assumptions and ignores questionable cost-effectiveness for RSV prophylaxis Value in Health. 13: 684. PMID 20412545 DOI: 10.1111/J.1524-4733.2010.00723.X |
0.558 |
|
| 2010 |
Hampp C, Saidi AS, Winterstein AG. Palivizumab Utilization and Compliance: Trends in Respiratory Syncytial Virus Prophylaxis in Florida Journal of Pediatrics. 156. PMID 20223478 DOI: 10.1016/J.Jpeds.2009.12.016 |
0.524 |
|
| 2009 |
Hampp C, Kauf T, Saidi A, Winterstein A. PRS17 COST-EFFECTIVENESS OF RESPIRATORY SYNCYTIAL VIRUS PROPHYLAXIS WITH PALIVIZUMAB FROM THE PERSPECTIVE OF A SOUTHERN US MEDICAID AGENCY Value in Health. 12: A301-A302. DOI: 10.1016/S1098-3015(10)74479-X |
0.492 |
|
| 2008 |
Hampp C, Winterstein AG. Response to respiratory synctial virus Southern Medical Journal. 101. PMID 18364631 DOI: 10.1097/Smj.0B013E3181611D5F |
0.456 |
|
| Show low-probability matches. |